{"database": "press", "table": "releases", "rows": [["https://hudson.house.gov/press-releases/hudson-health-legislation-passes-committee", "Hudson Health Legislation Passes Committee", "2023-12-12", "2023", "2023-12", "Republican", "House", "NC", "Richard Hudson", "H001067", "hudson.house.gov", "hudson", "https://hudson.house.gov/media/press-releases", "scraper", "WASHINGTON, DC - Last week, Congressman Richard Hudson (NC-09) announced his bill, H.R. 1352,the Increasing Access to Biosimilars Act of 2023, passed through a House Energy and Commerce committee legislative markup with bipartisan support. The legislation will now move to the House floor for final passage.\n\n\u201cAmericans deserve every option for affordable prescription drugs.\u201d said Rep. Hudson \u201cThat is why I stopped at no end to get this bill through the Committee by working with my colleagues across the aisle and negotiating the best opportunities to provide affordable medicines. I look forward to continuing to move this bill all the way to the President\u2019s desk.\u201d\n\nThe Increasing Access to Biosimilars Act of 2023 would require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products through Medicare.\n\nThe Increasing Access to Biosimilars Act of 2023 was reported to the Full House, as amended, by a roll call vote of 44 yeas to 0 nays.", 1, "2026-03-30T01:40:41Z", "2026-04-08T01:14:16Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://hudson.house.gov/press-releases/hudson-health-legislation-passes-committee"], "units": {}, "query_ms": 0.8745389059185982, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}